Cargando…
Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies
Adoptive cell therapy is an emerging anti-cancer modality, whereby the patient’s own immune cells are engineered to express T-cell receptor (TCR) or chimeric antigen receptor (CAR). CAR-T cell therapies have advanced the furthest, with recent approvals of two treatments by the Food and Drug Administ...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144572/ https://www.ncbi.nlm.nih.gov/pubmed/32204371 http://dx.doi.org/10.3390/molecules25061396 |